isonicotinamide

We are isonicotinamide CAS:1453-82-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:isonicotinamide
CAS.NO:1453-82-3
Synonyms:isonicotinamide
Pyridine-4-carboxamide
Isonicotinamide
4-Pyridinecarboxamide
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 334.4±15.0 °C at 760 mmHg
Melting Point 155-157 °C(lit.)
Molecular Formula C6H6N2O
Molecular Weight 122.125
Flash Point 156.0±20.4 °C
 
Specification:
Appearance:White to off-white crystalline powder
Assay:≥99.0%
Moisture:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Loratadine(CAS:79794-75-5).

isonicotinamide


Related News: The use of contrast agents is different from other drugs, and it needs to be used with corresponding equipment. In recent years, China is in the growth period of imaging equipment.2-(4-aminomethylphenyl)benzamide CAS:866946-42-1 There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space.2646-91-5 Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.2-Methyl-5-nitropyridine CAS:21203-68-9 Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.The Company’s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).

Related Products
Product Name
3-(Trifluoromethoxy)bromobenzene View Details
2-Fluoro-4-methylbenzaldehyde View Details
7-Azabenzotriazol-1-Yloxytris(Dimethylamino)Phosphonium Hexafluorophosphate View Details
(10-Phenylanthracen-9-yl)boronic acid manufacturer 3,5-dimethyl-4-nitro-1-oxidopyridin-1-ium manufacturer 3-Nitrophthalic acid manufacturer 2,5-Dibromo-4-methylpyridine manufacturer ethyl 5-(ethoxycarbonylsulfamoyl)-1-methylpyrazole-4-carboxylate manufacturer